Filter
708
Filtered Results: 708
Text search:
Licensed
pharmaceutical
products
Featured
Recommendations
65
New Publications
181
Language
Document type
No document type
294
Studies & Reports
184
Guidelines
109
Manuals
57
Strategic & Response Plan
40
Training Material
9
Fact sheets
9
Situation Updates
5
Resource Platforms
1
Countries / Regions
Global
37
Kenya
30
India
17
Nigeria
16
South Africa
14
Uganda
14
Ethiopia
14
Ghana
13
Western and Central Europe
12
Liberia
12
Sierra Leone
11
Rwanda
10
Zimbabwe
9
Philippines
9
Latin America and the Carribbean
9
Nepal
8
Ukraine
8
Tanzania
8
Zambia
8
Africa
7
Eastern Europe and Central Asia
7
Bangladesh
7
Malawi
6
Myanmar / Burma
6
Syria
5
West and Central Africa
5
South–East Asia Region
5
East and Southern Africa
5
Thailand
4
Cambodia
4
Namibia
4
Botswana
4
Benin
3
Laos
3
Senegal
3
Asia
3
Middle East and North Africa
3
Indonesia
3
Eswatini/ Swaziland
3
North Macedonia
2
Tajikistan
2
Cameroon
2
Burkina Faso
2
Mozambique
2
Congo, Democratic Republic of
2
Western Pacific Region
2
North America
2
United Kingdom
2
Eastern Europe
2
Timor Leste/ East Timor
1
Serbia
1
Lesotho
1
Kazakhstan
1
Iran
1
Albania
1
Kyrgyzstan
1
Uzbekistan
1
Mongolia
1
Bulgaria
1
Guinea
1
Armenia
1
Haiti
1
Venezuela
1
Gabon
1
Vietnam
1
Brazil
1
Moldova
1
Russia
1
Sudan
1
Georgia
1
Mali
1
Angola
1
South Sudan
1
Somalia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
264
Clinical Guidelines
70
Public Health
50
Key Resources
27
Pharmacy & Technologies
24
Women & Child Health
20
Capacity Building
4
Toolboxes
AMR
83
Pharmacy
71
COVID-19
47
Mental Health
30
NTDs
30
TB
28
HIV
27
Planetary Health
23
Rapid Response
22
Health Financing Toolbox
19
Caregiver
18
Global Health Education
17
Conflict
15
NCDs
13
Ebola & Marburg
9
Specific Hazards
5
Refugee
3
Disability
3
Polio
2
Natural Hazards
1
Social Ethics
1
Am. J. Trop. Med. Hyg., 106 (Suppl 5), 2022, pp. 56–60. Lymphatic filariasis (LF) is a parasitic disease that is a major cause of chronic disability in the developing world. According to the 2021–2030 road map for neglected tropical diseases (NTDs) published by the World Health Organization (WHO...
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition
Therapeutics Information and Pharmacovigilance Centre | TIPC
The active participation and engagement of health and care workers (HCWs) in health emergency preparedness, readiness and response is crucial to support risk communication, community engagement and infodemic management (RCCE-IM) interventions during emergencies. HCWs hold unique position...
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate ...
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
Interim policy guidance
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0169530 February 16, 2017
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
